Jacobs Levy Equity Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.11M	Sell	372,637 -180,742	-33%	-$3.5M	0.03%	339
2025 Q4	$11.9M	Buy	553,379 +291,048	+111%	+$6.13M	0.05%	279
2025 Q3	$5.06M	Buy	262,331 +17,798	+7%	+$317K	0.02%	424
2025 Q2	$4.18M	Buy	+244,533	New	+$10.4M	0.02%	480
2024 Q4	–	Sell	-753,845	Closed	-$94.1M	–	1037
2024 Q3	$94.1M	Buy	753,845 +63,437	+9%	+$8.77M	0.36%	68
2024 Q2	$109M	Buy	690,408 +110,771	+19%	+$14.2M	0.45%	52
2024 Q1	$75M	Buy	579,637 +120,535	+26%	+$14.8M	0.34%	73
2023 Q4	$44.3M	Buy	459,102 +61,646	+16%	+$5.91M	0.22%	104
2023 Q3	$48.2M	Sell	397,456 -48,117	-11%	-$5.44M	0.29%	78
2023 Q2	$51M	Sell	445,573 -36,423	-8%	-$4.7M	0.29%	85
2023 Q1	$66.4M	Buy	481,996 +6,095	+1%	+$791K	0.41%	56
2022 Q4	$61.7M	Sell	475,901 -26,292	-5%	-$3.05M	0.42%	59
2022 Q3	$55.5M	Buy	502,193 +66,383	+15%	+$6.69M	0.44%	52
2022 Q2	$32.7M	Sell	435,810 -2,235	-0.5%	-$164K	0.25%	110
2022 Q1	$34.2M	Buy	438,045 +9,311	+2%	+$713K	0.23%	109
2021 Q4	$38.6M	Buy	428,734 +330,949	+338%	+$28.3M	0.26%	102
2021 Q3	$9.04M	Buy	97,785 +4,835	+5%	+$372K	0.06%	321
2021 Q2	$7.23M	Buy	92,950 +3,953	+4%	+$300K	0.05%	365
2021 Q1	$6.63M	Buy	+88,997	New	+$8.21M	0.05%	373
2020 Q3	–	Sell	-2,943	Closed	-$472K	–	1102
2020 Q2	$472K	Buy	+2,943	New	+$400K	0.01%	797
2016 Q3	–	Sell	-18,300	Closed	-$349K	–	1122
2016 Q2	$349K	Buy	+18,300	New	+$339K	0.01%	849